Literature DB >> 27521604

STAT3-induced WDR1 overexpression promotes breast cancer cell migration.

Joo Hyun Lee1, Ji Eun Kim1, Baek Gil Kim2, Hyun Ho Han1, Suki Kang3, Nam Hoon Cho4.   

Abstract

WD repeat domain 1 (WDR1), a protein that assists cofilin-mediated actin filament disassembly, is overexpressed in the invading front of invasive ductal carcinoma (IDC), but its implication of overexpression and how to be regulated have not been studied. In our study, we demonstrated that STAT3 bound to the 5' upstream sequence (-1971 to -1964), a putative promoter region, of WDR1 gene, and its activation induced WDR1 overexpression in breast cancer cells. The exogenous overexpression of WDR1 increased the migration of MDA-MB-231, which was attenuated by WDR1 knockdown. In the analysis of breast cancer patients, WDR1 overexpression was associated with a shorter distant metastasis-free survival (DMFS), more specifically in basal-like tumors.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cell migration; Promoter binding; STAT3; Transcription factor; WDR1 (AIP1)

Mesh:

Substances:

Year:  2016        PMID: 27521604     DOI: 10.1016/j.cellsig.2016.08.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  11 in total

Review 1.  Functions of actin-interacting protein 1 (AIP1)/WD repeat protein 1 (WDR1) in actin filament dynamics and cytoskeletal regulation.

Authors:  Shoichiro Ono
Journal:  Biochem Biophys Res Commun       Date:  2017-10-19       Impact factor: 3.575

2.  TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration.

Authors:  Zhang Jianwei; Li Qi; Xu Quanquan; Wang Tianen; Wang Qingwei
Journal:  Pathol Oncol Res       Date:  2017-05-02       Impact factor: 3.201

3.  Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer.

Authors:  Madhuri Jayathirtha; Anca-Narcisa Neagu; Danielle Whitham; Shelby Alwine; Costel C Darie
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

4.  Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies.

Authors:  Abdallah Turky; Ashraf H Bayoumi; Farag F Sherbiny; Khaled El-Adl; Hamada S Abulkhair
Journal:  Mol Divers       Date:  2020-08-23       Impact factor: 2.943

5.  WDR1 predicts poor prognosis and promotes cancer progression in hepatocellular carcinoma.

Authors:  Linhui Zheng; Fang Hu; Jiaxi Li; Zhiwen Wang; Li Deng; Benping Xiao; Jianfeng Li; Xiong Lei
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

6.  WDR1 Promotes Cell Growth and Migration and Contributes to Malignant Phenotypes of Non-small Cell Lung Cancer through ADF/cofilin-mediated Actin Dynamics.

Authors:  Baiyin Yuan; Ruirui Zhang; Jisheng Hu; Zhongying Liu; Chao Yang; Tongcun Zhang; Chenxi Zhang
Journal:  Int J Biol Sci       Date:  2018-06-08       Impact factor: 6.580

7.  Low Expression of ASK1-Interacting Protein-1 Is Significantly Correlated with Tumor Angiogenesis and Poor Survival in Patients with Early Stage Non-Small Cell Lung Cancer.

Authors:  Chengyu Chen; Qun Geng; Dongfeng Sun; Wensi Hu; Chenxi Zhong; Limin Fan; Xiaoming Song
Journal:  Onco Targets Ther       Date:  2019-12-10       Impact factor: 4.147

8.  miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.

Authors:  Min Yue Zhang; Lu Qian Wang; Chor Sang Chim
Journal:  Cell Commun Signal       Date:  2021-05-27       Impact factor: 7.525

9.  WD Repeat Domain 1 Deficiency Inhibits Neointima Formation in Mice Carotid Artery by Modulation of Smooth Muscle Cell Migration and Proliferation.

Authors:  JiSheng Hu; ShangJing Pi; MingRui Xiong; ZhongYing Liu; Xia Huang; Ran An; TongCun Zhang; BaiYin Yuan
Journal:  Mol Cells       Date:  2020-08-31       Impact factor: 5.034

10.  VWCE Functions as a Tumor Suppressor in Breast Cancer Cells.

Authors:  Dan Zhang; Lili Wan; Fan Yang; Wenlan Liu; Litao Liu; Shengnan He; Ni Xie
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.